Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer

Abstract Background Due to experimental batch effects, the application of a quantitative transcriptional signature for disease diagnoses commonly requires inter-sample data normalization, which would be hardly applicable under common clinical settings. Many cancers might have qualitative differences...

Full description

Bibliographic Details
Main Authors: Qingzhou Guan, Haidan Yan, Yanhua Chen, Baotong Zheng, Hao Cai, Jun He, Kai Song, You Guo, Lu Ao, Huaping Liu, Wenyuan Zhao, Xianlong Wang, Zheng Guo
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Genomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12864-018-4446-y
_version_ 1828850374204719104
author Qingzhou Guan
Haidan Yan
Yanhua Chen
Baotong Zheng
Hao Cai
Jun He
Kai Song
You Guo
Lu Ao
Huaping Liu
Wenyuan Zhao
Xianlong Wang
Zheng Guo
author_facet Qingzhou Guan
Haidan Yan
Yanhua Chen
Baotong Zheng
Hao Cai
Jun He
Kai Song
You Guo
Lu Ao
Huaping Liu
Wenyuan Zhao
Xianlong Wang
Zheng Guo
author_sort Qingzhou Guan
collection DOAJ
description Abstract Background Due to experimental batch effects, the application of a quantitative transcriptional signature for disease diagnoses commonly requires inter-sample data normalization, which would be hardly applicable under common clinical settings. Many cancers might have qualitative differences with the non-cancer states in the gene expression pattern. Therefore, it is reasonable to explore the power of qualitative diagnostic signatures which are robust against experimental batch effects and other random factors. Results Firstly, using data of technical replicate samples from the MicroArray Quality Control (MAQC) project, we demonstrated that the low-throughput PCR-based technologies also exist large measurement variations for gene expression even when the samples were measured in the same test site. Then, we demonstrated the critical limitation of low stability for classifiers based on quantitative transcriptional signatures in applications to individual samples through a case study using a support vector machine and a naïve Bayesian classifier to discriminate colorectal cancer tissues from normal tissues. To address this problem, we identified a signature consisting of three gene pairs for discriminating colorectal cancer tissues from non-cancer (normal and inflammatory bowel disease) tissues based on within-sample relative expression orderings (REOs) of these gene pairs. The signature was well verified using 22 independent datasets measured by different microarray and RNA_seq platforms, obviating the need of inter-sample data normalization. Conclusions Subtle quantitative information of gene expression measurements tends to be unstable under current technical conditions, which will introduce uncertainty to clinical applications of the quantitative transcriptional diagnostic signatures. For diagnosis of disease states with qualitative transcriptional characteristics, the qualitative REO-based signatures could be robustly applied to individual samples measured by different platforms.
first_indexed 2024-12-12T23:10:43Z
format Article
id doaj.art-e4b0bcd36fa145f8b6c00a1ea6b17206
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-12-12T23:10:43Z
publishDate 2018-01-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-e4b0bcd36fa145f8b6c00a1ea6b172062022-12-22T00:08:36ZengBMCBMC Genomics1471-21642018-01-0119111110.1186/s12864-018-4446-yQuantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancerQingzhou Guan0Haidan Yan1Yanhua Chen2Baotong Zheng3Hao Cai4Jun He5Kai Song6You Guo7Lu Ao8Huaping Liu9Wenyuan Zhao10Xianlong Wang11Zheng Guo12Fujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityCollege of Bioinformatics Science and Technology, Harbin Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityCollege of Bioinformatics Science and Technology, Harbin Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityFujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical UniversityAbstract Background Due to experimental batch effects, the application of a quantitative transcriptional signature for disease diagnoses commonly requires inter-sample data normalization, which would be hardly applicable under common clinical settings. Many cancers might have qualitative differences with the non-cancer states in the gene expression pattern. Therefore, it is reasonable to explore the power of qualitative diagnostic signatures which are robust against experimental batch effects and other random factors. Results Firstly, using data of technical replicate samples from the MicroArray Quality Control (MAQC) project, we demonstrated that the low-throughput PCR-based technologies also exist large measurement variations for gene expression even when the samples were measured in the same test site. Then, we demonstrated the critical limitation of low stability for classifiers based on quantitative transcriptional signatures in applications to individual samples through a case study using a support vector machine and a naïve Bayesian classifier to discriminate colorectal cancer tissues from normal tissues. To address this problem, we identified a signature consisting of three gene pairs for discriminating colorectal cancer tissues from non-cancer (normal and inflammatory bowel disease) tissues based on within-sample relative expression orderings (REOs) of these gene pairs. The signature was well verified using 22 independent datasets measured by different microarray and RNA_seq platforms, obviating the need of inter-sample data normalization. Conclusions Subtle quantitative information of gene expression measurements tends to be unstable under current technical conditions, which will introduce uncertainty to clinical applications of the quantitative transcriptional diagnostic signatures. For diagnosis of disease states with qualitative transcriptional characteristics, the qualitative REO-based signatures could be robustly applied to individual samples measured by different platforms.http://link.springer.com/article/10.1186/s12864-018-4446-yClassifiersDiagnostic signatureRelative expression orderingsPlatformBatch effects
spellingShingle Qingzhou Guan
Haidan Yan
Yanhua Chen
Baotong Zheng
Hao Cai
Jun He
Kai Song
You Guo
Lu Ao
Huaping Liu
Wenyuan Zhao
Xianlong Wang
Zheng Guo
Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
BMC Genomics
Classifiers
Diagnostic signature
Relative expression orderings
Platform
Batch effects
title Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
title_full Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
title_fullStr Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
title_full_unstemmed Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
title_short Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
title_sort quantitative or qualitative transcriptional diagnostic signatures a case study for colorectal cancer
topic Classifiers
Diagnostic signature
Relative expression orderings
Platform
Batch effects
url http://link.springer.com/article/10.1186/s12864-018-4446-y
work_keys_str_mv AT qingzhouguan quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT haidanyan quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT yanhuachen quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT baotongzheng quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT haocai quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT junhe quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT kaisong quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT youguo quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT luao quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT huapingliu quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT wenyuanzhao quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT xianlongwang quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer
AT zhengguo quantitativeorqualitativetranscriptionaldiagnosticsignaturesacasestudyforcolorectalcancer